{"created":"2023-06-19T10:43:43.443531+00:00","id":4011,"links":{},"metadata":{"_buckets":{"deposit":"f445cb36-babc-4e58-8e53-ea734712e9e4"},"_deposit":{"created_by":11,"id":"4011","owners":[11],"pid":{"revision_id":0,"type":"depid","value":"4011"},"status":"published"},"_oai":{"id":"oai:shiga-med.repo.nii.ac.jp:00004011","sets":["30:66:216","77:280:281"]},"author_link":["564","7753","7548","802","7755"],"item_4_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2021-10-12","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{},{"bibliographic_title":"The journal of obstetrics and gynaecology research","bibliographic_titleLang":"en"}]}]},"item_4_creator_3":{"attribute_name":"著者別名","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"花田, 哲郎"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"木村, 文則"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"北澤, 純"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"森宗, 愛菜"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"村上, 節"}],"nameIdentifiers":[{},{},{}]}]},"item_4_description_14":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"pdf","subitem_description_type":"Other"}]},"item_4_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Postoperative hormone therapy for hormone-sensitive patients with breast cancer is important to prevent a recurrence. As hormone therapy does not induce infertility in patients, fertility-preserving therapy is not provided during treatment. Here, however, we performed controlled ovarian stimulation and embryo freezing for fertility preservation under the influence of a sustained-release gonadotropin-releasing hormone agonist in a patient with breast cancer whose postoperative treatment plan was changed from hormone therapy to chemotherapy. After oocyte retrieval, the patient developed treatment-resistant severe symptomatic ovarian hyperstimulation syndrome. Following treatment with oral gonadotropin-releasing hormone antagonist, her symptoms immediately improved, and she could receive chemotherapy on schedule.","subitem_description_type":"Abstract"}]},"item_4_description_42":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"Journal Article","subitem_description_type":"Other"}]},"item_4_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Wiley"}]},"item_4_relation_10":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"34636462","subitem_relation_type_select":"PMID"}}]},"item_4_relation_11":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"10.1111/jog.15059"}],"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1111/jog.15059","subitem_relation_type_select":"DOI"}}]},"item_4_rights_12":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"© 2021 Japan Society of Obstetrics and Gynecology. "}]},"item_4_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1447-0756","subitem_source_identifier_type":"ISSN"}]},"item_4_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"HANADA, Tetsuro"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"KIMURA, Fuminori"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"KITAZAWA, Jun"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"MORIMUNE, Aina"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"MURAKAMI, Takashi"}],"nameIdentifiers":[{},{},{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2022-10-12"}],"displaytype":"detail","filename":"jog.15059.pdf","filesize":[{"value":"382.7 kB"}],"format":"application/pdf","license_note":"© 2021 Japan Society of Obstetrics and Gynecology. ","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"jog.15059","url":"https://shiga-med.repo.nii.ac.jp/record/4011/files/jog.15059.pdf"},"version_id":"4612e852-372c-436e-9f1d-d2ceb4b23525"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"breast cancer","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"gonadotropin-releasing hormone agonist","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"gonadotropin-releasing hormone antagonist","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"oncofertility","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"ovarian hyperstimulation syndrome","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Impact of an oral gonadotropin-releasing hormone antagonist on severe ovarian hyperstimulation syndrome in a patient with breast cancer who received a sustained-release gonadotropin-releasing hormone agonist : A case report.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Impact of an oral gonadotropin-releasing hormone antagonist on severe ovarian hyperstimulation syndrome in a patient with breast cancer who received a sustained-release gonadotropin-releasing hormone agonist : A case report."}]},"item_type_id":"4","owner":"11","path":["216","281"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-11-02"},"publish_date":"2021-11-02","publish_status":"0","recid":"4011","relation_version_is_last":true,"title":["Impact of an oral gonadotropin-releasing hormone antagonist on severe ovarian hyperstimulation syndrome in a patient with breast cancer who received a sustained-release gonadotropin-releasing hormone agonist : A case report."],"weko_creator_id":"11","weko_shared_id":-1},"updated":"2023-06-19T11:21:18.799314+00:00"}